Search research articles
Contact Us
Filters
Showing results (81-90 of 143) with videos related to
Page
of 15
Sort By:
Oxidative Medicine and Cellular Longevity
|
December 26, 2018
Dark Chocolate Intake Positively Modulates Redox Status and Markers of Muscular Damage in Elite Football Athletes: A Randomized Controlled Study
Elena Cavarretta, Mariangela Peruzzi, Riccardo Del Vescovo, et al.
Clinical Lung Cancer
|
August 5, 2019
The Prognostic Role of TNM Staging Compared With Tumor Volume and Number of Pleural Sites in Malignant Pleural Mesothelioma
Claudia Proto, Diego Signorelli, Sandra Mallone, et al.
British Journal of Cancer
|
November 26, 2019
Association of the prognostic model iSEND with PD-1/L1 monotherapy outcome in non-small-cell lung cancer
Wungki Park, Laura Mezquita, Naoyuki Okabe, et al.
JCO Global Oncology
|
April 6, 2021
OncoAlert Round Table Discussions: The Global COVID-19 Experience
Gilberto Morgan, Evandro de Azambuja, Kevin Punie, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 26, 2024
Segmentectomy vs. Lobectomy in stage IA non-small cell lung cancer: A systematic review and meta-analysis of perioperative and survival outcomes
Luca Bertolaccini, Antonino Carmelo Tralongo, Marzia Del Re, et al.
Translational Lung Cancer Research
|
July 18, 2020
Integrating clinical and biological prognostic biomarkers in patients with advanced NSCLC treated with immunotherapy: the DEMo score system
Arsela Prelaj, Claudia Proto, Giuseppe Lo Russo, et al.
ESMO Open
|
April 10, 2019
Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors
Giovanni Fucà, Giulia Galli, Marta Poggi, et al.
Cancers
|
April 3, 2021
Beyond First-Line Immunotherapy: Potential Therapeutic Strategies Based on Different Pattern Progressions: Oligo and Systemic Progression
Arsela Prelaj, Chiara Carlotta Pircher, Giacomo Massa, et al.
Journal of Translational Medicine
|
July 31, 2024
Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung)
Fabrizio Citarella, Kazuki Takada, Priscilla Cascetta, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 17, 2019
Survival of patients with non-small cell lung cancer having leptomeningeal metastases treated with immune checkpoint inhibitors
Lizza E L Hendriks, Gerben Bootsma, Jean Mourlanette, et al.
Page
of 15
Search research articles
Search
Showing results (81-90 of 143) with videos related to
Sort By:
Page
of 15
Oxidative Medicine and Cellular Longevity
|
December 26, 2018
Dark Chocolate Intake Positively Modulates Redox Status and Markers of Muscular Damage in Elite Football Athletes: A Randomized Controlled Study
Elena Cavarretta, Mariangela Peruzzi, Riccardo Del Vescovo, et al.
Clinical Lung Cancer
|
August 5, 2019
The Prognostic Role of TNM Staging Compared With Tumor Volume and Number of Pleural Sites in Malignant Pleural Mesothelioma
Claudia Proto, Diego Signorelli, Sandra Mallone, et al.
British Journal of Cancer
|
November 26, 2019
Association of the prognostic model iSEND with PD-1/L1 monotherapy outcome in non-small-cell lung cancer
Wungki Park, Laura Mezquita, Naoyuki Okabe, et al.
JCO Global Oncology
|
April 6, 2021
OncoAlert Round Table Discussions: The Global COVID-19 Experience
Gilberto Morgan, Evandro de Azambuja, Kevin Punie, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 26, 2024
Segmentectomy vs. Lobectomy in stage IA non-small cell lung cancer: A systematic review and meta-analysis of perioperative and survival outcomes
Luca Bertolaccini, Antonino Carmelo Tralongo, Marzia Del Re, et al.
Translational Lung Cancer Research
|
July 18, 2020
Integrating clinical and biological prognostic biomarkers in patients with advanced NSCLC treated with immunotherapy: the DEMo score system
Arsela Prelaj, Claudia Proto, Giuseppe Lo Russo, et al.
ESMO Open
|
April 10, 2019
Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors
Giovanni Fucà, Giulia Galli, Marta Poggi, et al.
Cancers
|
April 3, 2021
Beyond First-Line Immunotherapy: Potential Therapeutic Strategies Based on Different Pattern Progressions: Oligo and Systemic Progression
Arsela Prelaj, Chiara Carlotta Pircher, Giacomo Massa, et al.
Journal of Translational Medicine
|
July 31, 2024
Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung)
Fabrizio Citarella, Kazuki Takada, Priscilla Cascetta, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 17, 2019
Survival of patients with non-small cell lung cancer having leptomeningeal metastases treated with immune checkpoint inhibitors
Lizza E L Hendriks, Gerben Bootsma, Jean Mourlanette, et al.
Page
of 15